Knee cartilage patch study halted early

NCT ID NCT04537013

Terminated Disease control Sponsor: Geistlich Pharma AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special collagen patch (Chondro-Gide) placed over large knee cartilage injuries could help people recover as well as standard microfracture surgery for smaller injuries. The study planned to enroll 82 people aged 18-55 with knee cartilage damage. However, the study was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARTILAGE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

articular cartilage disorder Cartilage Diseases Fractures, Stress Knee Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARTILAGE DISEASE CARTILAGE INJURY KNEE DISCOMFORT KNEE INJURIES

Contacts and locations

Locations

Emory Sports Medicine Complex

Johns Creek, Georgia, 30097, United States
Fraser Orthopaedic Institute

New Westminster, British Columbia, V3L 0E4, Canada
Gelenkzentrum Mittelrhein GmbH

Mayen, Mayen, 63 D-56727, Germany
Hamilton Health Sciences

Hamilton, Ontario, L8N 3Z5, Canada
Orthopaedic Foundation

Stamford, Connecticut, 06905, United States
Orthopädische Chirurgie München

München, 81369, Germany
Regio Kliniken GmbH

Pinneberg, Schleswig-Holstein, 25421, Germany
Sportklinik Ravensburg

Ravensburg, Germany
St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada
Sunnybrook Research Institute (SRI)

Toronto, Ontario, M4N 3M5, Canada
The MORE Foundation

Phoenix, Arizona, 85023, United States
University Hospital Regensburg

Regensburg, Germany
University of Calgary

Calgary, CGY, T2N5A1, Canada
University of Toronto Orthopaedics

Toronto, TOR, M5S 1B2, Canada
Universitätsklinikum Schleswig Holstein Campus Lübeck

Lübeck, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.